MHRA Drug Safety Update July 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on:

  • Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia.
  • Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine.
  • Letters and medicine recalls sent to healthcare professionals in June 2023.

To see the latest MHRA Drug Safety Updates in full, visit the website.

Support the call for more funding by recording the informal advice you provide over just one day.

Click Here